148 related articles for article (PubMed ID: 38169767)
1. Association Between Apolipoprotein B and Coronary Artery Disease Among Hypertensive Patients: A Systematic Review of the Prospective and Retrospective Studies.
Nathir I; Abd Aziz F; Hashim R
Cureus; 2023 Dec; 15(12):e49854. PubMed ID: 38169767
[TBL] [Abstract][Full Text] [Related]
2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
3. Effect of hypertension and cardiac hypertrophy on coronary artery morphology in sudden cardiac death.
Burke AP; Farb A; Liang YH; Smialek J; Virmani R
Circulation; 1996 Dec; 94(12):3138-45. PubMed ID: 8989121
[TBL] [Abstract][Full Text] [Related]
4. Role of the apolipoprotein B-apolipoprotein A-I ratio in cardiovascular risk assessment: a case-control analysis in EPIC-Norfolk.
van der Steeg WA; Boekholdt SM; Stein EA; El-Harchaoui K; Stroes ES; Sandhu MS; Wareham NJ; Jukema JW; Luben R; Zwinderman AH; Kastelein JJ; Khaw KT
Ann Intern Med; 2007 May; 146(9):640-8. PubMed ID: 17470832
[TBL] [Abstract][Full Text] [Related]
5. Quantitation of plasma apolipoproteins in the primary and secondary prevention of coronary artery disease.
Rader DJ; Hoeg JM; Brewer HB
Ann Intern Med; 1994 Jun; 120(12):1012-25. PubMed ID: 8185133
[TBL] [Abstract][Full Text] [Related]
6. Coronary artery disease is associated with the ratio of apolipoprotein A-I/B and serum concentration of apolipoprotein B, but not with paraoxonase enzyme activity in Iranian subjects.
Rahmani M; Raiszadeh F; Allahverdian S; Kiaii S; Navab M; Azizi F
Atherosclerosis; 2002 Jun; 162(2):381-9. PubMed ID: 11996958
[TBL] [Abstract][Full Text] [Related]
7. Genetic study of common variants at the Apo E, Apo AI, Apo CIII, Apo B, lipoprotein lipase (LPL) and hepatic lipase (LIPC) genes and coronary artery disease (CAD): variation in LIPC gene associates with clinical outcomes in patients with established CAD.
Baroni MG; Berni A; Romeo S; Arca M; Tesorio T; Sorropago G; Di Mario U; Galton DJ
BMC Med Genet; 2003 Sep; 4():8. PubMed ID: 12964943
[TBL] [Abstract][Full Text] [Related]
8. Association between plasma lipids, and apolipoproteins and coronary artery disease: a cross-sectional study in a low-risk Korean population.
Kim HK; Chang SA; Choi EK; Kim YJ; Kim HS; Sohn DW; Oh BH; Lee MM; Park YB; Choi YS
Int J Cardiol; 2005 Jun; 101(3):435-40. PubMed ID: 15907412
[TBL] [Abstract][Full Text] [Related]
9. Apolipoprotein polymorphisms fail to define risk of coronary artery disease. Results of a prospective, angiographically controlled study.
Marshall HW; Morrison LC; Wu LL; Anderson JL; Corneli PS; Stauffer DM; Allen A; Karagounis LA; Ward RH
Circulation; 1994 Feb; 89(2):567-77. PubMed ID: 8313545
[TBL] [Abstract][Full Text] [Related]
10. Stress echocardiography for the diagnosis of coronary artery disease: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2010; 10(9):1-61. PubMed ID: 23074412
[TBL] [Abstract][Full Text] [Related]
11. Single photon emission computed tomography for the diagnosis of coronary artery disease: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2010; 10(8):1-64. PubMed ID: 23074411
[TBL] [Abstract][Full Text] [Related]
12. Is increased apolipoprotein B-A major factor enhancing the risk of coronary artery disease in type 2 diabetes?
Snehalatha C; Ramachandran A; Sivasankari S; Satyavani K; Viswanathan V; Misra J; Girinath MR; Sathyamurthy I
J Assoc Physicians India; 2002 Aug; 50():1036-8. PubMed ID: 12421026
[TBL] [Abstract][Full Text] [Related]
13. Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.
Osborne SR; Alston LV; Bolton KA; Whelan J; Reeve E; Wong Shee A; Browne J; Walker T; Versace VL; Allender S; Nichols M; Backholer K; Goodwin N; Lewis S; Dalton H; Prael G; Curtin M; Brooks R; Verdon S; Crockett J; Hodgins G; Walsh S; Lyle DM; Thompson SC; Browne LJ; Knight S; Pit SW; Jones M; Gillam MH; Leach MJ; Gonzalez-Chica DA; Muyambi K; Eshetie T; Tran K; May E; Lieschke G; Parker V; Smith A; Hayes C; Dunlop AJ; Rajappa H; White R; Oakley P; Holliday S
Med J Aust; 2020 Dec; 213 Suppl 11():S3-S32.e1. PubMed ID: 33314144
[TBL] [Abstract][Full Text] [Related]
14. Correlation of fasting serum apolipoprotein B-48 with coronary artery disease prevalence.
Masuda D; Sugimoto T; Tsujii K; Inagaki M; Nakatani K; Yuasa-Kawase M; Tsubakio-Yamamoto K; Ohama T; Nishida M; Ishigami M; Kawamoto T; Matsuyama A; Sakai N; Komuro I; Yamashita S
Eur J Clin Invest; 2012 Sep; 42(9):992-9. PubMed ID: 22587365
[TBL] [Abstract][Full Text] [Related]
15. Single effects of apolipoprotein B, (a), and E polymorphisms and interaction between plasminogen activator inhibitor-1 and apolipoprotein(a) genotypes and the risk of coronary artery disease in Czech male caucasians.
Benes P; Muzík J; Benedík J; Frélich M; Elbl L; Vasků A; Znojil V; Vácha J
Mol Genet Metab; 2000 Feb; 69(2):137-43. PubMed ID: 10720441
[TBL] [Abstract][Full Text] [Related]
16. Stress echocardiography with contrast for the diagnosis of coronary artery disease: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2010; 10(10):1-59. PubMed ID: 23074387
[TBL] [Abstract][Full Text] [Related]
17. APOE gene ɛ4 allele (388C-526C) effects on serum lipids and risk of coronary artery disease in southern Chinese Hakka population.
Liu Q; Wu H; Yu Z; Huang Q; Zhong Z
J Clin Lab Anal; 2021 Sep; 35(9):e23925. PubMed ID: 34313350
[TBL] [Abstract][Full Text] [Related]
18. Association of lipids, lipoproteins, apolipoproteins and paraoxonase enzyme activity with premature coronary artery disease.
Azizi F; Rahmani M; Raiszadeh F; Solati M; Navab M
Coron Artery Dis; 2002 Feb; 13(1):9-16. PubMed ID: 11917194
[TBL] [Abstract][Full Text] [Related]
19. Clinical significance of measurements of serum apolipoprotein A-I, A-II and B in hypertriglyceridemic male patients with and without coronary artery disease.
Kukita H; Hamada M; Hiwada K; Kokubu T
Atherosclerosis; 1985 May; 55(2):143-9. PubMed ID: 3924067
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
